1,380
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1

, , , , , & show all
Pages 744-752 | Received 09 Aug 2018, Accepted 05 Sep 2019, Published online: 03 Nov 2019

References

  • An X, Zhang AL, Yang AW, Lin L, Wu D, Guo X, Shergis JL, Thien FC, Worsnop CJ, Xue CC. 2011. Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review. Respir Med. 105(2):165–176.
  • Barr TL, Latour LL, Lee KY, Schaewe TJ, Luby M, Chang GS, El-Zammar Z, Alam S, Hallenbeck JM, Kidwell CS, Warach S. 2010. Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke. 41(3):e123–e128.
  • Barreiro E, Criner GJ. 2014. Update in chronic obstructive pulmonary disease 2013. Am J Respir Crit Care Med. 189(11):1337–1344.
  • Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, et al. 2012. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 185(10):1065–1072.
  • Chaudhuri R, McSharry C, Spears M, Brady J, Grierson C, Messow CM, Miele G, Nocka K, MacNee W, Connell M, et al. 2013. Sputum matrix metalloproteinase-9 is associated with the degree of emphysema on computed tomography in COPD. Transl Respir Med. 1(1):11–11.
  • Di Stefano A, Caramori G, Capelli A, Gnemmi I, Ricciardolo FL, Oates T, Donner CF, Chung KF, Barnes PJ, Adcock IM. 2004. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J. 24(1):78–85.
  • Dong L, Xia JW, Gong Y, Chen Z, Yang HH, Zhang J, He J, Chen XD. 2014. Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease. Evid Based Complement Alternat Med. 2014:637969.
  • Dong R, Xie L, Zhao K, Zhang Q, Zhou M, He P. 2016. Cigarette smoke-induced lung inflammation in COPD mediated via LTB4/BLT1/SOCS1 pathway. Int J Chron Obstruct Pulmon Dis. 11:31–41.
  • Gentry S, Gentry B. 2017. Chronic obstructive pulmonary disease: diagnosis and management. Am Fam Physician. 95(7):433–441.
  • Grzela K, Litwiniuk M, Zagorska W, Grzela T. 2016. Airway remodeling in chronic obstructive pulmonary disease and asthma: the role of matrix metalloproteinase-9. Arch Immunol Ther Exp (Warsz). 64(1):47–55.
  • Hackett TL, Shaheen F, Zhou S, Wright JL, Churg A. 2014. Fibroblast signal transducer and activator of transcription 4 drives cigarette smoke-induced airway fibrosis. Am J Respir Cell Mol Biol. 51(6):830–839.
  • Huang X, Tan H, Chen B, Deng C. 2010. [Influence of astragalosides and Panax notoginseng saponins compatibility on MMP-9 and TIMP-1 after cerebral ischemia-reperfusion in mice]. Zhongguo Zhong Yao Za Zhi. 35:2187–2191.
  • Kawayama T, Kinoshita T, Matsunaga K, Kobayashi A, Hayamizu T, Johnson M, Hoshino T. 2016. Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls. Int J Chron Obstruct Pulmon Dis. 11:295–303.
  • Kim SW, Kim ES, Moon CM, Kim TI, Kim WH, Cheon JH. 2012. Abnormal genetic and epigenetic changes in signal transducer and activator of transcription 4 in the pathogenesis of inflammatory bowel diseases. Dig Dis Sci. 57(10):2600–2607.
  • Li H, Yang T, Li FY, Ning Q, Sun ZM. 2016. TLR4 Overexpression inhibits endothelial pas domain-containing protein 1 expression in the lower respiratory tract of patients with chronic COPD. Cell Physiol Biochem. 39(2):685–692.
  • Li SY, Li JS, Wang MH, Xie Y, Yu XQ, Sun ZK, Ma LJ, Zhang W, Zhang HL, Cao F, Pan YC. 2012. Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study. BMC Complement Altern Med. 12:197–197.
  • Li Y, Li SY, Li JS, Deng L, Tian YG, Jiang SL, Wang Y, Wang YY. 2012. A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection. Biol Pharm Bull. 35(10):1752–1760.
  • Li Y, Lu Y, Zhao Z, Wang J, Li J, Wang W, Li S, Song L. 2016. Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis. J Res Med Sci. 21:12.
  • Mullings RE, Wilson SJ, Puddicombe SM, Lordan JL, Bucchieri F, Djukanovic R, Howarth PH, Harper S, Holgate ST, Davies DE. 2001. Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol. 108(5):832–838.
  • Osuka S, Hashimoto N, Sakamoto K, Wakai K, Yokoi K, Hasegawa Y. 2015. Risk stratification by the lower limit of normal of FEV1/FVC for postoperative outcomes in patients with COPD undergoing thoracic surgery. Respir Investig. 53(3):117–123.
  • Page BD, Croucher DC, Li ZH, Haftchenary S, Jimenez-Zepeda VH, Atkinson J, Spagnuolo PA, Wong YL, Colaguori R, Lewis AM, et al. 2013. Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myeloma. J Med Chem. 56(18):7190–7200.
  • Raherison C. 2011. [Epidemiology of chronic obstructive pulmonary disease]. Rev Prat. 61:769–773.
  • Shi Q, Liu Z, Yang Y, Geng P, Zhu YY, Zhang Q, Bai F, Bai G. 2009. Identification of anti-asthmatic compounds in Pericarpium citri reticulatae and evaluation of their synergistic effects. Acta Pharmacol Sin. 30(5):567–575.
  • Wang C, Ding H, Tang X, Li Z, Gan L. 2017a. Effect of liuweibuqi capsules in pulmonary alveolar epithelial cells and COPD through JAK/STAT pathway. Cell Physiol Biochem. 43(2):743–756.
  • Wang C, Ding H, Tang X, Li Z, Gan L. 2017b. Effect of Liuweibuqi capsules on the balance between MMP-9 and TIMP1 and viability of alveolar macrophages in COPD. Biosci Rep. 37. DOI:10.1042/BSR20170880
  • Wang C, Li Z, Liu X, Peng Q, Li F, Li D, Wang C. 2015. Effect of Liuweibuqi capsule, a Chinese patent medicine, on the JAK1/STAT3 pathway and MMP9/TIMP1 in a chronic obstructive pulmonary disease rat model. J Tradit Chin Med. 35(1):54–62.
  • Wu L, Chen Y, Xu Y, Guo X, Li X, Zhang AL, May BH, Xue CC, Wen Z, Lin L. 2013. Oral huangqi formulae for stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2013:705315.
  • Wu X, Feng X, He Y, Gao Y, Yang S, Shao Z, Yang C, Wang H, Ye Z. 2016. IL-4 administration exerts preventive effects via suppression of underlying inflammation and TNF-α-induced apoptosis in steroid-induced osteonecrosis. Osteoporos Int. 27(5):1827–1837.
  • Yao H, Hwang JW, Sundar IK, Friedman AE, McBurney MW, Guarente L, Gu W, Kinnula VL, Rahman I. 2013. SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD. Am J Physiol Lung Cell Mol Physiol. 305(9):L615–624.
  • Zizzo G, Cohen PL. 2013. IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J Immunol. 190(10):5237–5246.